Myrtelle
WAKEFIELD, MA · Biotechnology · 13 employees
Myrtelle Inc. is a patient-centered, innovation-driven gene therapy company transforming the treatment of neurological diseases. Our mission is to develop and deliver novel treatments for devastating disorders of the central nervous system, beginning with our lead program, gene therapy treatment for Canavan disease.
Funding history
- Funding Round — $30.5M — Dec 2025
- Funding Round — $7.5M — Mar 2025
- Funding Round — $6.0M — Jun 2024
- Funding Round — $15.7M — Oct 2022
- Funding Round — $13.5M — Jul 2021
Recent signals
- Dec 23, 2025: Raised $30.5M
- Mar 21, 2025: Raised $7.5M
- Jun 10, 2024: Raised $6.0M
- Oct 17, 2022: Raised $15.7M
- Jul 08, 2021: Raised $13.5M
- Jun 24, 2021: Raised $13.5M
See plans & pricing → Track Myrtelle’s funding, hiring, and signals — with verified contacts — on Fundz.